No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the Depression Case Control (DeCC) study and a meta-analysis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 6, 2008, Pages 699-706

  Gaysina, D ^a,b   Cohen, S ^a   Craddock, N ^c   Farmer, A ^a   Hoda, F ^a   Korszun, A ^d   Owen, M J ^c   Craig, I W ^a   McGuffin, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Association; Depression; Folate; Meta analysis; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; MONOAMINE;

ARTICLE; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NEUROTRANSMISSION; PRIORITY JOURNAL; RECURRENT DISEASE; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE;

EID: 51449097924     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30665     Document Type: Article

References (42)

1. Alpert JE, Mischoulon D, Nierenberg AA, Fava M. 2000. Nutrition and depression: Focus on folate. Nutrition 16:544-546.
2. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. 1997. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74:526-528.
3. Beck AT, Steer RA. 1984. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365-1367.
4. Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
5. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. 2003. Folate, vitamin B12, homocysteine, and the MTHFR 677C → T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 60:618-626.
6. Bondy B, Baghai TC, Zill P, Bottlender R, Jaeger M, Minov C, et al. 2002. Combined action of the ACE D- and the G-protein β3 T-allele in major depression: A possible link to cardiovascular disease? Mol Psychiatry 7:1120-1126.
7. Bottiglieri T, Hyland K, Reynolds EH. 1994. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 48:137-152.
8. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. 2000. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 69:228-232.
9. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol 151:862-877.
10. Chen CS, Tsai JC, Tsang HY, Kuo YT, Lin HF, Chiang IC, et al. 2005. Homocysteine levels, MTHFR C677T genotype, and MRI hyperintensities in lateonset major depressive disorder. Am J Geriatr Psychiatry 13:869-875.
11. Coppen A, Bailey J. 2000. Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. J Affect Disord 60:121-130.
12. Dupont WD, Plummer WD. 1990. Power and sample size calculations: A review and computer program. Control Clin Trials 11:116-1128.
13. Emigh TH. 1980. A comparison of tests for Hardy-Weinberg equilibrium. Biometrics 36:627-642.
14. Fleiss JL. 1981. Statistical methods for rates and proportions. 2nd edition. New York: John Wiley. pp 38-46.
15. Freeman B, Powell J, Ball D, Hill L, Craig I, Plomin R. 1997. DNA by mail: An inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet 27:251-257.
16. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. 2003. DNA from buccal swabs recruited by mail: Evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33:67-72.
17. Geisel J, Hubner U, Bodis M, Schorr H, Knapp JP, Obeid R, et al. 2003. The role of genetic factors in the development of hyperhomocysteinemia. Clin Chem Lab Med 41:1427-1434.
18. Gilbody S, Lewis S, Lightfoot T. 2007. Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review. Am J Epidemiol 165:1-13.
19. Heux S, Morin F, Lea RA, Ovcaric M, Tajouri L, Griffiths LR. 2004. The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res 27:663-667.
20. Hickie I, Scott E, Naismith S, Turner K, Scott E, Mitchell P, et al. 2001. Late-onset depression: Genetic, vascular and clinical contributions. Psychol Med 31:1403-1412.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327:557-560.
22. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
23. Kelly CB, McDonnell AP, Johnston TG, Mulholland C, Cooper SJ, McMaster D, et al. 2004. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol 18:567-571.
24. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, et al. 2002. MTHFR 677C → T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 288:2023-2031.
25. Kunugi H, Fukuda R, Hattori M, Kato T, Tatsumi M, Sakai T, et al. 1998. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3:435-437.
26. Lewis SJ, Lawlor DA, Davey Smith G, Araya R, Timpson N, Day IN, Ebrahim S. 2006. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 11:352-360.
27. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, et al. 1997. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17:1157-1162.
28. McGuffin P, Katz R, Aldrich J. 1986. Past and present state examination: The assessment of 'lifetime ever' psychopathology. Psychol Med 16:461-465.
29. McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, et al. 2005. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 14:3337-3345.
30. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al. 1997. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 349:1591-1593.
31. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK. 1998. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 128:1336-1341.
32. Reif A, Pfuhlmann B, Lesch KP. 2005. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 29:1162-1168.
33. Rozen R. 1996. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 19:589-594.
34. Salanti G, Sanderson S, Higgins JP. 2005. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7:13-20.
35. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, et al. 2006. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 59:372-375.
36. Schlesselman JJ. 1982. Case-control studies: Design, conduct, analysis. New York: Oxford U. Press. pp 144-152.
37. Tan EC, Chong SA, Lim LC, Chan AO, Teo YY, Tan CH, et al. 2004. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 14:227-231.
38. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. 2001. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22:195-201.
39. van Praag HM. 1982. Depression. Lancet 2:1259-1283.
40. Wigginton JE, Cutler DJ, Abecasis GR. 2005. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76:887-893.
41. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. 1990. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47:589-593.
42. Zintzaras E. 2006. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: A meta-analysis of genetic association studies. Psychiatr Genet 16:105-115.